Luis A. Vigara

Cadiz, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative GN in Kidney Transplantation.

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative GN in Kidney Transplantation.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 16, 2026

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative Glomerulonephritis in Kidney Transplantation.

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative Glomerulonephritis in Kidney Transplantation.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 16, 2026

Emphysematous Pyelonephritis After Embolization of a Nonfunctioning Kidney Graft.

Emphysematous Pyelonephritis After Embolization of a Nonfunctioning Kidney Graft.

Journal: Nephrology (Carlton, Vic.)

Published: January 30, 2026

Roxadustat for Refractory Anemia Associated to Cytomegalovirus Infection in Kidney Transplantation.

Roxadustat for Refractory Anemia Associated to Cytomegalovirus Infection in Kidney Transplantation.

Journal: Transplantation proceedings

Published: August 13, 2025

De novo IgA nephropathy in a kidney transplant recipient after SARS-CoV-2 vaccination.

De novo IgA nephropathy in a kidney transplant recipient after SARS-CoV-2 vaccination.

Journal: Nefrologia

Published: April 19, 2024

Management of Dyslipidemia With Evolocumab in Kidney Transplant Recipients.

Management of Dyslipidemia With Evolocumab in Kidney Transplant Recipients.

Journal: Transplantation

Published: February 06, 2024

Treatment with PCSK9 inhibitors in patients with chronic kidney disease at very high cardiovascular risk.

Treatment with PCSK9 inhibitors in patients with chronic kidney disease at very high cardiovascular risk.

Journal: Nefrologia

Published: January 31, 2024

Benefits of Routine Screening for Renal Cell Carcinoma of Native Kidney in Renal Transplant Recipients.

Benefits of Routine Screening for Renal Cell Carcinoma of Native Kidney in Renal Transplant Recipients.

Journal: Transplantation proceedings

Published: August 30, 2023

Real-world experience with mild-moderate COVID-19 therapies in kidney transplant patients: How to treat patients with chronic kidney disease from now on?

Real-world experience with mild-moderate COVID-19 therapies in kidney transplant patients: How to treat patients with chronic kidney disease from now on?

Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia

Published: June 12, 2023

Real-world experience with mild-moderate COVID-19 therapies in kidney transplant patients: How to treat patients with chronic kidney disease from now on?

Real-world experience with mild-moderate COVID-19 therapies in kidney transplant patients: How to treat patients with chronic kidney disease from now on?

Journal: Nefrologia

Published: June 12, 2023

Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients.

Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients.

Journal: Nefrologia

Published: March 29, 2023

High exposure to tacrolimus is associated with spontaneous remission of recurrent membranous nephropathy after kidney transplantation.

High exposure to tacrolimus is associated with spontaneous remission of recurrent membranous nephropathy after kidney transplantation.

Journal: Clinical kidney journal

Published: January 25, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026